Protection of mice against SV40 tumours by Pam3Cys, MTP-PE and Pam3Cys conjugated with the SV40 T antigen-derived peptide, K(698)-T(708)-Reference-Cited by-同舟云学术

Protection of mice against SV40 tumours by Pam3Cys, MTP-PE and Pam3Cys conjugated with the SV40 T antigen-derived peptide, K(698)-T(708)

Published:1998-01 Issue:2-3 Volume:16 Page:161-169
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Obert Matthias,Pleuger Hendrik,Hanagarth Hans-Günter,Schulte-Mönting Jürgen,Wiesmüller Karl-Heinz,Braun Dietmar G.,Brandner Gerhard,Hess Ralf D.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference57 articles.

1. Molecular Biology of Tumor Viruses: DNA Tumor Viruses;Tooze,1980

2. Fundamental Immunology;Schreiber,1989

3. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein);Tevethia;Virology,1980

4. Relationship between T antigen and tumor-specific transplantation antigen in simian virus 40-transformed cells;Chang;J. Virol.,1979

5. Demonstration of multiple antigenic sites of the SV40 transplantation rejection antigen by using cytotoxic T lymphocyte clones;Campbell;J. Immunol.,1983

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines;Vaccine;2012-04

2. TLR Ligand–Peptide Conjugate Vaccines;Synthetic Vaccines;2012

3. Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer;Angewandte Chemie International Edition;2011-01-07

4. Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer;Angewandte Chemie;2011-01-07

5. Synthesis of Toll-Like Receptor-2 Targeting Lipopeptides as Self-Adjuvanting Vaccines;Peptide-Based Drug Design;2008